Years ago, as I began my career as an investor, I read a book by Peter Lynch. Mr. Lynch had made his name, and his fortune, as the manager of Fidelity’s flagship Magellan fund in the late 70’s and ’80’s, and his incredible performance was one of the big reasons Magellan, at the time, was […]
Read MoreAs we move into the last few months of the year, the sad and simple truth is that, no matter how much we might want to be able stop including COVID-19 and its impact on every aspect of life in our daily discussions, the health crisis hasn’t gone away, but instead is showing more persistence […]
Read MoreAs recently as a few months ago, a lot of signs about the global pandemic seemed to suggest that the worst of the worst was over, and we could all finally begin to put COVID-19 concerns and commentary in the rear view. As contagious variants of the virus have emerged, however, it has become more […]
Read MoreCan’t find what you need at the store again? You’re not alone. As the world reaches the two-year mark of the COVID-19 pandemic, more items are becoming scarce because of a supply chain shortage across the globe. Supply chain concerns are due to “record-level congestion at the Port of Los Angeles/Long Beach that has spread […]
Read MoreEven in 2019 B.C. (Before Coronavirus), millions of Americans were filled with anxiety about retirement. Would they really be able to stop working? Would they outlive their savings? What about the steady rise in healthcare costs? On and on. Not surprisingly, the upheaval caused by the pandemic has added to this uncertainty. Nearly a quarter […]
Read MoreLooking for value in the stock market is something that I have found can be done in any market condition, but it is something that tends to get dismissed by most pundits simply because it isn’t very sexy. Names like Tesla, Netflix, and Amazon practically never make the value list because the massive amount of […]
Read MoreEver since coronavirus found its way to American shores, a lot of media attention has been given to the Healthcare sector – and especially to the Biotechnology industry, where many of the biggest names across the world have been working hard to develop effective treatments for the disease. Available vaccines are now available for distribution […]
Read MoreOne of the interesting trends that seems to inevitably come out of periods of economic uncertainty is investor rotation into “defensive” sectors, which usually includes Utilities, Consumer Staples and other pockets of the market that investors tend to think of as safe havens when market uncertainty is high. Another favorite topic analysts seem to like […]
Read MoreBioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is involved in the developing of FixVac product candidates, including BNT111, which is in Phase I clinical trial for advance melanoma; BNT112 that is in Phase I/IIa trial for prostate cancer; BNT113, which is in Phase I/II trial […]
Read MoreLooking for value in the stock market is something that I have found can be done in any market condition, but it is something that tends to get dismissed by most pundits simply because it isn’t very sexy. Names like Tesla, Netflix, and Amazon practically never make the value list because the massive amount of […]
Read MoreCisco Systems Inc. (CSCO) is one of the most recognizable and established companies in the Technology sector. With a market cap of about $193 billion, they are also one of the largest, if not THE largest player in the Networking & Communications segment. They are, without question, the standard that all other networking businesses are […]
Read MoreThere is a lot of fundamental data that I rely on to help paint an overall picture about underlying strength of any stock I might consider using for a value-based investment. While some fundamental investors prefer to work with easy-to-reference, quick-glance data like earnings per share, I prefer to expand my view of a company’s […]
Read MoreI have written quite a bit about how I like to pay attention to stocks in the Food Products industry when market conditions become more uncertain and broad volatility starts to increase. That’s because while the industry itself can hardly be described as disruptive – in fact, I’ve seen analysts throughout the year dismiss the […]
Read MoreIn market terms, one of the natural side effects of the COVID-19 health crisis has been an elevated focus on stocks in the Healthcare sector. That covers a wide range of industries, from health insurance to biopharmaceutical and healthcare equipment and supplies. All of these companies have spent the last eighteen months not only coping […]
Read MoreAs much as everybody is anxious to put the pandemic and COVID-19 concerns and commentary in the rear view, the practical reality is that the aftermath – which includes dealing with ongoing health concerns – will continue to extend through the rest of the year. In the United States, it’s tempting to say that the […]
Read More